Gatehouse Bio
Natick
About Gatehouse Bio
Gatehouse Bio is a biotech company developing effective therapeutics using AI that harnesses the power of small RNA. Their platform discovers disease-associated mutations and designs therapeutics to counteract their effect. We believe there is an RNA code that can treat every disease Our mission is to find that code and use it to develop effective therapeutics Our platform uses AI to discover mutations in small RNA genes and design oligonucleotides that crack a disease’s code Our pipeline and partnerships are focused on developing drugs for therapeutic areas with known heterogeneity (Fibrosis, Inflammation, Neurodegeneration) With every single code we break, we unlock the potential to improve the lives of many
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.9M
- Funding stage: Seed
- Last round: Convertible Note (Sep 2024)
- Website: gatehousebio.com
- Phone: 408-439-8967
Industries & Categories
Artificial Intelligence (AI), Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/gatehouse-bio-74590 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.